Page last updated: 2024-08-24

naphthalimides and Neoplasm Metastasis

naphthalimides has been researched along with Neoplasm Metastasis in 8 studies

Research

Studies (8)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's5 (62.50)18.2507
2000's0 (0.00)29.6817
2010's3 (37.50)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Dai, F; Feng, C; Ge, C; He, H; Li, Q; Wang, C; Wang, Y; Xie, S; Xu, X1
Li, Q; Li, Z; Wang, CJ; Xie, SQ; Zhang, YH; Zhao, J1
Borad, MJ; Chalasani, P; Kurtin, S; Mahadevan, D; Northfelt, DW; Rensvold, D; Tibes, R; Von Hoff, DD1
Depisch, D; Dittrich, C; Fazeny, B; Haider, K; Kornek, G; Raderer, M; Scheithauer, W1
Kennedy, MJ1
Berkowitz, I; Berry, D; Costanza, ME; Duggan, D; Henderson, IC; Kalra, J; Lyss, AP; Ratain, MJ; Shapiro, C; Wu, K1
Alberts, DE; Gallion, HH; Hynes, HE; Liu, PY; Mills, G; O'Sullivan, J; O'Toole, RV; Smith, HO1
Depisch, D; Haider, K; Kornek, G; Scheithauer, W1

Reviews

1 review(s) available for naphthalimides and Neoplasm Metastasis

ArticleYear
Metastatic breast cancer.
    Current opinion in oncology, 1996, Volume: 8, Issue:6

    Topics: Adenine; Antibodies, Monoclonal; Antibodies, Neoplasm; Antimetabolites, Antineoplastic; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Aromatase Inhibitors; Bone Neoplasms; Breast Neoplasms; Clinical Trials as Topic; Clinical Trials, Phase II as Topic; Deoxycytidine; Diphosphonates; Docetaxel; Doxorubicin; Enzyme Inhibitors; Female; Gemcitabine; Humans; Imides; Intercalating Agents; Isoquinolines; Naphthalimides; Neoplasm Metastasis; Neoplasm Proteins; Organophosphonates; Paclitaxel; Randomized Controlled Trials as Topic; Salvage Therapy; Taxoids; Topoisomerase II Inhibitors; Treatment Outcome

1996

Trials

4 trial(s) available for naphthalimides and Neoplasm Metastasis

ArticleYear
Phase I trial of UNBS5162, a novel naphthalimide in patients with advanced solid tumors or lymphoma.
    International journal of clinical oncology, 2013, Volume: 18, Issue:5

    Topics: Adult; Aged; Aged, 80 and over; Animals; Dogs; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug-Related Side Effects and Adverse Reactions; Female; Humans; Lymphoma; Male; Maximum Tolerated Dose; Mice; Middle Aged; Naphthalimides; Neoplasm Metastasis; Neoplasm Staging; Rats; Urea

2013
Amonafide as first-line chemotherapy for metastatic breast cancer.
    European journal of cancer (Oxford, England : 1990), 1994, Volume: 30A, Issue:3

    Topics: Adenine; Adult; Aged; Agranulocytosis; Antineoplastic Agents; Breast Neoplasms; Female; Humans; Imides; Isoquinolines; Middle Aged; Naphthalimides; Nausea; Neoplasm Metastasis; Organophosphonates; Treatment Outcome; Vomiting

1994
Amonafide: An active agent in the treatment of previously untreated advanced breast cancer--a cancer and leukemia group B study (CALGB 8642).
    Clinical cancer research : an official journal of the American Association for Cancer Research, 1995, Volume: 1, Issue:7

    Topics: Adenine; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cyclophosphamide; Doxorubicin; Drug Administration Schedule; Female; Fluorouracil; Humans; Imides; Isoquinolines; Menopause; Middle Aged; Naphthalimides; Neoplasm Metastasis; Organophosphonates; Receptors, Estrogen

1995
Phase II trial of amonafide in previously treated patients with advanced ovarian cancer: a Southwest Oncology Group study.
    Gynecologic oncology, 1992, Volume: 46, Issue:2

    Topics: Adenine; Adult; Aged; Cisplatin; Drug Administration Schedule; Drug Evaluation; Female; Humans; Imides; Isoquinolines; Middle Aged; Naphthalimides; Neoplasm Metastasis; Neoplasm Recurrence, Local; Neoplasm Staging; Organophosphonates; Ovarian Neoplasms

1992

Other Studies

3 other study(ies) available for naphthalimides and Neoplasm Metastasis

ArticleYear
Design, Synthesis, and Biological Evaluation of Mitochondria-Targeted Flavone-Naphthalimide-Polyamine Conjugates with Antimetastatic Activity.
    Journal of medicinal chemistry, 2017, 03-09, Volume: 60, Issue:5

    Topics: Cell Line; Drug Design; Flavones; Humans; Mitochondria; Naphthalimides; Neoplasm Metastasis; Polyamines; Reactive Oxygen Species

2017
BND-12, a novel nonhaematotoxic naphthalimide derivative, inhibits tumour growth and metastasis of hepatocellular carcinoma.
    The Journal of pharmacy and pharmacology, 2012, Volume: 64, Issue:10

    Topics: Adenine; Animals; Antineoplastic Agents; Apoptosis; Carcinoma, Hepatocellular; Cell Line, Tumor; Cell Proliferation; Drug Screening Assays, Antitumor; Humans; Liver Neoplasms; Male; Mice; Mitochondria; Naphthalimides; Neoplasm Metastasis; Organophosphonates; Survival Rate; Toxicity Tests; Xenograft Model Antitumor Assays

2012
Amonafide in metastatic colorectal carcinoma.
    European journal of cancer (Oxford, England : 1990), 1990, Volume: 26, Issue:8

    Topics: Adenine; Aged; Antineoplastic Agents; Colorectal Neoplasms; Female; Humans; Imides; Isoquinolines; Male; Middle Aged; Naphthalimides; Neoplasm Metastasis; Organophosphonates

1990